Factual end-of-day data for NATCOPHARM: price and volume, delivery percentage, 52-week position, indicator levels and intraday order flow. Refreshed after every NSE session.
Traded volume of 3,71,204 shares was close to the 20-day average.
The session opened +1.24% away from the previous close.
NATCOPHARM's delivery share of 46.6% was in line with its 20-day average of 45.8%.
Intraday order-flow data from VolumeLens tick classification — the running difference between aggressive buying and selling volume. This dataset is not published by any other Indian platform.
Large-trade volume split: 2,846 shares on the buy side vs 3,784 on the sell side.
Largest single buy-side trade: 1,423 shares at ₹868.50.
| Indicator | Reading (26 Aug 2026) |
|---|---|
| RSI (14) | 35.3 |
| 50-day EMA | ₹926.50 — close is below |
| 200-day EMA | ₹950.78 — close is below |
| SuperTrend (10, 3) | ₹959.69 — close is below the line |
Indicator values are computed from adjusted daily closes and describe where price sits relative to each level — they are statistics, not signals.
NATCOPHARM is a mid-cap NSE stock in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry), with a market capitalisation of about ₹16,221 crore.
Footprint chart, DOM ladder, cumulative delta and volume profile — free to explore.
On 26 Aug 2026, 46.6% of NATCOPHARM's traded volume was marked for delivery (1,72,898 shares delivered). The 20-day average delivery is 45.8%.
NATCOPHARM closed at ₹863.40 on 26 Aug 2026 (-0.33% vs the previous close).
52-week high ₹1,226.80, 52-week low ₹789.00. The latest close is -29.62% from the 52-week high.